↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

37 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Afinitor   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   2件:
34,
158 
 2   Antiepileptic drug (1 to 3 only)   -   -   -   -   1件:
158 
 3   Aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231 
 4   Bumetanide   Bumetanide   D00247   -   -   2件:
6,
158 
 5   Calcitriol   Calcitriol   D00129   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 6   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 7   Cannabidiol (cbd)   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   2件:
140,
158 
 8   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 9   Everolimus   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   8件:
34,
67,
89,
96,
137,
157,
158,
277 
 10   Everolimus (rad001)   Everolimus, rad001   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   3件:
34,
89,
158 
 11   Gwp42003-p   -   -   -   -   5件:
140,
144,
145,
156,
158 
 12   L04aa18   -   -   -   -   1件:
158 
 13   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 14   Metformin (generic)   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   1件:
158 
 15   Metformin hydrochloride   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   3件:
81,
158,
265 
 16   Npc-12g gel   -   -   -   -   1件:
158 
 17   Open label rad001 (only used for post-extension phase)   rad001   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   1件:
158 
 18   Petrolatum   Petrolatum   D05304, D05331   -   -   3件:
35,
158,
162 
 19   Propranolol   Propranolol   D00483, D08443   3件: ADRB1, ADRB2, ADRB3   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   5件:
6,
158,
167,
227,
278 
 20   Rad001   rad001   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   5件:
34,
67,
89,
96,
158 
 21   Rad001 2,5 mg   rad001   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   1件:
158 
 22   Rapamune   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   5件:
2,
60,
66,
67,
158 
 23   Rapamune 1 mg/ml solución oral   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   1件:
158 
 24   Rapamycin   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   16件:
2,
15,
34,
35,
46,
49,
51,
60,
61,
67,
86,
89,
158,
256,
278,
279 
 25   Rapamycin, sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   2件:
89,
158 
 26   Rapamycin-calcitriol combination   Calcitriol, Sirolimus   D00129, D00753   2件: MTOR, VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Pathways in cancer, mTOR signaling pathway   1件:
158 
 27   Simvastatin   Simvastatin   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 28   Sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 29   Sirolimus 0.2%   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   1件:
158 
 30   Sirolimus 0.4%   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   1件:
158 
 31   Skincerity   -   -   -   -   2件:
34,
158 
 32   Skincerity plus sirolimus/rapamycin   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   2件:
34,
158 
 33   Skinercity plus sirolimus/rapamycin   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   2件:
34,
158 
 34   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 35   Turmeric   Turmeric   -   -   -   4件:
140,
144,
158,
299 
 36   Vigabatrin   Vigabatrin   D00535   1件: ABAT   1件: GABAergic synapse   2件:
145,
158 
 37   Votubia   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   2件:
34,
158 

先頭へ